Filing Details

Accession Number:
0001209191-23-021708
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-30 18:59:29
Reporting Period:
2023-03-29
Accepted Time:
2023-03-30 18:59:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1620463 Athira Pharma Inc. ATHA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1225501 A James Johnson C/O Athira Pharma, Inc.
18706 North Creek Parkway, Suite 104
Bothell WA 98011
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-29 5,000 $2.40 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct